about
Virologic and serologic outcomes of mono versus dual HBV therapy and characterization of HIV/HBV coinfection in a US cohort.Reducing Postsurgical Wound Complications: A Critical Review.Implementing an Inpatient Pediatric Prospective Audit and Feedback Antimicrobial Stewardship Program Within a Larger Medical Center.Preventing Infections in Children with Cancer.Multilayer Model of Pharmacy Participation in the Antimicrobial Stewardship Program at a Large Academic Medical Center.Binding of trans-acting factors to the double-stranded variant surface glycoprotein (VSG) expression site promoter of Trypanosoma bruceiEvaluation of Meropenem Extended Versus Intermittent Infusion Dosing Protocol in Critically Ill PatientsDalbavancin Use in the Emergency Department SettingThe Cost Effectiveness of Birth-Cohort Hepatitis C Screening During Pre-Admission Testing for Elective Procedures at a Single Specialty Orthopedic Hospital
P50
Q34213161-A7CFF571-A251-42CD-A5F5-866D76304474Q36375443-46F801FF-9687-44F0-8D07-E086A72BDA1CQ38621533-A50FC303-AB81-4BB3-8C2C-9996A79A9E57Q38851043-10B050F8-F627-429C-9F2E-04C264547DB5Q48558479-124C2F2C-067A-4D05-9406-E35D3C3F942FQ73698823-ADC856E9-C753-409B-9512-F5AAC9CC4C32Q89315751-E14313E3-9766-4A10-AE9D-70C520DBF8B6Q92475105-29846CDC-7F35-4897-B73C-D13ECF79FFC2Q93123892-3F617D9A-6229-45AC-936A-F93C07C59E38
P50
description
onderzoeker
@nl
researcher, ORCID id # 0000-0003-3249-4415
@en
name
Vinh Pham
@ast
Vinh Pham
@en
Vinh Pham
@es
Vinh Pham
@nl
type
label
Vinh Pham
@ast
Vinh Pham
@en
Vinh Pham
@es
Vinh Pham
@nl
prefLabel
Vinh Pham
@ast
Vinh Pham
@en
Vinh Pham
@es
Vinh Pham
@nl
P106
P31
P496
0000-0003-3249-4415